# OnCo record nct07231211 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07231211/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07231211", "NCT07231211" ;
  schema:name "A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of Trastuzumab rezetecan in advanced solid tumours, run by Shanghai Shengdi Pharmaceutical Co., Ltd, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07231211/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07231211> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2025-11-20" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-rezetecan/> ;
  onco:companies <https://onco.cc/companies/hengrui/> .